Hindcon Chemicals Ltd
Chemicals & Petrochemicals | Small Cap
Hindcon Chemicals Ltd demonstrates a mixed financial performance. While the company shows strengths in solvency, coverage, and profitability, it struggles with liquidity, efficiency, and growth. The company maintains its ability to meet long-term obligations and has adequate interest coverage. Certain profitability metrics, such as gross profit margin, ROCE, and operating margin, are reasonably good. However, the company faces challenges in converting assets into sales and maintaining sufficient liquid assets. The negative growth rates in revenue, operating profit, and EPS raise concerns about its future prospects. Hindcon Chemicals Ltd needs to address these weaknesses to ensure sustainable financial health.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsOvervalued
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio2.00
- Financial Ratio4.00
- Profitability Ratio6.80
- Efficiency Ratio4.67
- Coverage Ratio6.80
- Solvency Ratio9.00
- Liquidity Ratio2.00
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourNeutral
- 2 HoursNeutral
- 4 HoursNeutral
- 1 DayNeutral
- 1 WeekNeutral
- 1 MonthNeutral
Hindcon Chemicals Ltd demonstrates a mixed financial performance. While the company shows strengths in solvency, coverage, and profitability, it struggles with liquidity, efficiency, and growth. The company maintains its ability to meet long-term obligations and has adequate interest coverage. Certain profitability metrics, such as gross profit margin, ROCE, and operating margin, are reasonably good. However, the company faces challenges in converting assets into sales and maintaining sufficient liquid assets. The negative growth rates in revenue, operating profit, and EPS raise concerns about its future prospects. Hindcon Chemicals Ltd needs to address these weaknesses to ensure sustainable financial health.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
Overall Valuation Score
P/E RATIO (TTM)
29.60
Industry Median
22.59
Small Cap Median
21.70
P/E RATIO
31.20
P/B RATIO
2.10
Industry Median
1.76
Small Cap Median
1.77
P/S RATIO
2.09
Industry Median
0.89
Small Cap Median
0.88
Others
PEG RATIO
5.51
EV/EBITDA RATIO
17.24
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹23.09 as on Jun 15, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
Quarterly Report⬤2nd Feb 26
Quarterly Financial Results Q3 FY 2025-26
BEARISH SENTIMENT
The growth ratios are generally weak, with negative growth rates in revenue, operating profit, EPS, and assets. This indicates that the company is facing challenges in expanding its operations and increasing its profitability. The company needs to address these issues to ensure sustainable growth. This could be due to market factors, increased competition, or internal inefficiencies.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 50.49 | 28.47 | -24.63 | -12.28 | 14.9 |
| Operating Profit Growth Rate | 9.43 | 3.61 | 37.33 | -40.28 | -13.68 |
| Earnings Per Share (EPS) Growth | -9.78 | 1.2 | 44.05 | -38.84 | -14.86 |
| Asset Growth Rate | 21.73 | 1.96 | 11.06 | 6.73 | 20.31 |
| Net Income Growth Rate | -10.69 | 2.35 | 42.89 | -38.52 | -19.58 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The financial ratios provide a mixed view. Cash EPS are positive, but adjusted EPS, book value per share, and dividend per share are low. Capital expenditures are reasonably good. Overall, the company shows some ability to generate cash earnings and invest in capital assets, but needs to improve its adjusted earnings, book value, and dividend payouts to enhance shareholder value. This may reflect strategic decisions regarding investment and shareholder returns.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 1.11 | 1.15 | 1.64 | 1 | 0.76 |
| Cash Earnings Per Share (Cash EPS) | 1.18 | 1.21 | 1.72 | 1.21 | 1.06 |
| Book Value Per Share | 10.22 | 11.06 | 13.04 | 14.1 | 14.83 |
| Dividend Per Share (DPS) | 0.26 | 0 | 0.15 | 0.45 | 0 |
| Capital Expenditures (CapEx) | 0.5 | 1.5 | 3.6 | 2.4 | 2.6 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The profitability ratios present a mixed performance. Gross profit margin, ROCE, and operating margin are good, indicating reasonable profitability from sales and capital investments. However, ROE and net margin are poor, suggesting issues with overall profitability and shareholder returns. The company needs to address these issues to enhance its overall profitability. This could be due to high operating costs or ineffective pricing strategies.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 7.11 | 5.7 | 10.46 | 6.04 | 4.06 |
| Return on Capital Employed (ROCE) | 15.69 | 14.34 | 17.87 | 9.97 | 7.85 |
| Return on Equity (ROE) | 10.88 | 10.3 | 12.47 | 7.09 | 5.39 |
| Return on Assets (ROA) | 9.48 | 9.64 | 11.92 | 6.67 | 4.78 |
| Operating Margin | 7.49 | 6.04 | 11.01 | 7.49 | 5.63 |
| Net Margin | 6.39 | 5.09 | 9.66 | 6.77 | 4.74 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The efficiency ratios show a mixed performance. While days sales in inventory and receivable days are reasonably good, fixed asset turnover, inventory turnover, receivables turnover, and capital turnover ratios are quite low. This indicates that the company is not effectively utilizing its assets to generate sales. This is balanced by adequate inventory and receivables management. The company needs to improve its asset management practices.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 38.73 | 33.3 | 10.32 | 7.96 | 7.45 |
| Inventory Turnover Ratio | 22.1 | 23.43 | 23.82 | 30.21 | 14.27 |
| Receivables Turnover Ratio | 2.92 | 3.26 | 2.66 | 2.58 | 2.94 |
| Days Sales in Inventory Ratio | 16.52 | 15.58 | 15.32 | 12.08 | 25.58 |
| Receivable Days | 125 | 111.96 | 137.22 | 141.47 | 124.15 |
| Capital Turnover Ratio | 1.7 | 2.02 | 1.29 | 1.05 | 1.14 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The coverage ratios present a mixed outlook. The interest coverage ratio is strong, indicating a good ability to meet interest obligations. However, the equity dividend coverage ratio is poor, suggesting limited ability to cover dividends with equity. Overall, the company demonstrates adequate financial safety in terms of debt obligations, but needs to improve its dividend-paying capacity.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 305.5 | 121.4 | 105.38 | 66.38 | 10.17 |
| Equity Dividend Coverage Ratio | 3.24 | 8.06 | 1.65 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The solvency position is strong, with low debt ratios and a high equity ratio. This indicates that the company relies more on equity than debt which is a sign of stability. This can also limit financial flexibility and growth potential, as the company may miss opportunities to leverage debt for expansion. The company's financial structure is quite stable.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0 | 0 | 0 | 0 | 0 |
| Debt to Equity Ratio | 0 | 0 | 0 | 0 | 0 |
| Equity Ratio | 1 | 1 | 1 | 1 | 1 |
| Debt To Asset Ratio | 0 | 0 | 0 | 0 | 0 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The liquidity position is weak, indicating potential difficulties in meeting short-term obligations. Low current, quick, and cash ratios suggest that the company has limited liquid assets to cover its immediate liabilities. This could pose challenges in managing day-to-day operations and unexpected expenses. On the other hand, It reflects the need for better working capital management.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 3.54 | 4.29 | 5.06 | 5.41 | 3.31 |
| Quick Ratio | 3.27 | 4 | 4.9 | 5.2 | 2.96 |
| Cash Ratio | 0.4 | 0.92 | 1.23 | 1.46 | 0.98 |
| Operating Cash Flow Ratio | -0.33 | 0.48 | 0.95 | 0.29 | -0.2 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Arvee Laboratories (India) Ltd | 7.86 | 71.67 | Highly Overvalued | 3.19 | 2.29 | 2.53 |
| 2 | Indian Emulsifiers Ltd | 7.24 | 5.17 | Neutral | 26.00 | 8.84 | 16.00 |
| 3 | Vital Chemtech Ltd | 7.20 | 25.50 | Neutral | 10.00 | 3.74 | 1.00 |
| 4 | Ambani Orgochem Ltd | 5.39 | 73.16 | Neutral | 16.00 | 1.77 | 1.00 |
| 5 | Hindcon Chemicals Ltd | 5.31 | 31.20 | Overvalued | 3.66 | 0.63 | 3.08 |
| 6 | Alkali Metals Ltd | 5.12 | -17.05 | Neutral | 7.72 | 0.55 | 0.56 |
Hindcon Chemicals' management demonstrates mixed performance. Strengths include healthy ROCE and ROE, alongside substantial promoter holding. Concerns arise from volatile sales growth and reliance on other income. Declining sales and profit growth in recent periods, coupled with working capital management inefficiencies, temper the overall assessment.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | ROCE | 17.87% | Capital being used productively |
| ROE | 13% | Shareholder funds yielding good returns | |
| Promoter Holding | 68.67% | Confidence and alignment with shareholders | |
| CONS | Sales Growth (TTM) | -20% | Declining revenue expansion |
| Profit Growth (TTM) | -13% | Declining profit growth |
Financial Performance & Growth
Hindcon Chemicals shows mixed financial growth, with historical compounded sales growth contrasting sharply with recent TTM sales decline. Profit growth mirrors this pattern. Quarterly figures reveal volatility, and reliance on other income complicates operational efficiency assessment.
| Metric | 2016-2018 | 2019-2021 | 2022-2024 | TTM |
|---|---|---|---|---|
| Sales Growth (%) | 11.58 | 18.79 | -3.6 | -20 |
| Profit Growth (%) | 28.53 | -5.82 | 43.97 | -13 |
Capital Efficiency & Returns
Hindcon Chemicals demonstrates reasonable capital efficiency. ROCE fluctuates but remains acceptable, and ROE suggests good returns on shareholder funds.
| Metric | Mar 2017 | Mar 2020 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| ROCE (%) | 19.92 | 13.98 | 14.34 | 17.87 |
| ROE (%) | N/A | N/A | N/A | 13 |
Financial Health & Prudence
Hindcon Chemicals exhibits good financial health, managing debt effectively with a low debt-to-equity ratio. The interest coverage ratio is comfortable, and the company shares profits through dividends.
| Metric | Mar 2017 | Mar 2020 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Borrowings | 5.02 | 0.30 | 0.98 | 0.00 |
Strategic & Operational Indicators
Hindcon Chemicals presents mixed strategic and operational indicators. Working capital management reveals inefficiencies with relatively high debtor and inventory days, leading to an extended cash conversion cycle.
| Metric | Mar 2017 | Mar 2020 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Debtor Days | 199.50 | 164.24 | 111.65 | 125.83 |
| Inventory Days | 13.08 | 22.98 | 17.35 | 12.03 |
The risk assessment for Hindcon Chemicals is moderate. Strengths like healthy ROCE and substantial promoter holding are balanced by declining sales and profit growth, inconsistencies in quarterly performance, and potential inefficiencies in working capital management.
Off-balance sheet exposure quantification
No specific data available.
Contingent liability evaluation
No specific data available.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 2 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 4 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Day Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Week Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Month Timeframe